What is MBOT's current stock price?

MBOT (Microbot Medical Inc.) is currently trading at $1.71 with a market cap of $77.9M.

What sector is Microbot Medical Inc. in?

Microbot Medical Inc. (MBOT) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.

Is MBOT a good stock to buy?

Analysts have a Buy consensus on MBOT with a price target of $5.50. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

MBOT Microbot Medical Inc.

Healthcare

$1.71-3.93%ClosedMarket Cap: $77.9M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

1.55

P/S

742.15

EV/EBITDA

-4.76

DCF Value

$0.07

FCF Yield

-19.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

-9.5%

Operating Margin

-15278.1%

Net Margin

-13535.2%

ROE

-21.8%

ROA

-18.2%

ROIC

-21.4%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$105.0K	$-3.7M	$—
Q4 null	$0.00	$-3.5M	$—
FY null	$0.00	$-13.1M	$—
Q3 null	$0.00	$-3.6M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$5.50

Target (Median)

$5.50

Target Range

$5.50 - $5.50

0 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell

HC Wainwright & Co.Buy

2026-04-14

HC Wainwright & Co.Buy

2025-11-28

HC Wainwright & Co.Buy

2025-10-15

HC Wainwright & Co.Buy

2025-09-11

Trading Activity

Insider Trades

View All

Wilson David Jamesdirector

SellFri Apr 03

Wenderow Tal Baruchdirector

SellFri Apr 03

Stockburger Aileen Ptuchadirector

SellFri Apr 03

Madden Martin J.director

SellFri Apr 03

Laxminarain Prattipatidirector

SellFri Apr 03

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

Exchange

—

Beta

1.06

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Peers